IGNX001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IGNX001, covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 [Phase 1]